Cellular, Tissue and Gene Therapies Advisory Committee
(Formerly Biological Response Modifiers Advisory Committee)
July 29, 2005 Meeting
Date and Time:
The meeting will be held on July 29, 2005; 12:30 p.m. to approximately 2:30 p.m.
Location:
National Institutes of Health, 8800 Rockville Pike, Building 29B, Conference Room C, Rockville, MD 20854. . This meeting will be held by teleconference. The public is welcome to attend the meeting at this location. A speakerphone will be provided for public participation in the meeting.
Contact Persons:
Gail Dapolito, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512389. Please call the Information Line for up-to-date information on this meeting.
Agenda:
In open session, the Committee will hear brief opening remarks and allow time for public participation and comments related to individual FDA research programs during the open public hearing. The Committee will not hear presentations or discuss individual research programs in the open session.
Oral Presentations:
Between approximately 12:30 and 1:30 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person by July 21, 2005.
Closed Committee Deliberations:
From approximately 1:30 to 2:30 p.m. the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c) (6)). The Committee will discuss individual FDA research programs.
|
